Loading...
Mycobacterium leprae Is Naturally Resistant to PA-824
Leprosy responds very slowly to the current multidrug therapy, and hence there is a need for novel drugs with potent bactericidal activity. PA-824 is a 4-nitroimidazo-oxazine that is currently undergoing phase I clinical trials for the treatment of tuberculosis. The activity of PA-824 against Mycoba...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology
2006
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1610092/ https://ncbi.nlm.nih.gov/pubmed/17005816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00488-06 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|